Vertex Completes $10 Billion Crinetics Acquisition at $85 a Share

Vertex closed its cash acquisition of Crinetics on Sept. 1, adding the launched acromegaly drug PALSONIFY and the late-stage endocrine candidate atumelnant.

Vertex closed its cash acquisition of Crinetics on Sept. 1, adding the launched acromegaly drug PALSONIFY and the late-stage endocrine candidate atumelnant.

Kiavi is now a wholly owned Figure subsidiary, while the closing filing reports about $590 million of cash consideration net of cash acquired within the broader $717 million structure announced in June.

The self-storage REIT said the completed deal adds 68 Canadian properties and 5.3 million rentable square feet, with most of the upfront consideration paid in OP units.

Enovis announced a binding offer to acquire French surgical-robotics developer eCential Robotics, with about €176 million of cash due to shareholders at closing and up to €35 million more tied to milestones.

Yext’s revenue fell 2% year over year, while adjusted EBITDA rose 29% as the company shifted further toward larger enterprise customers and expanded its AI-search products.

NCS Multistage is now a wholly owned Weatherford subsidiary and has left Nasdaq, as Weatherford begins integrating the completions and reservoir-diagnostics business.

KPN drew more than €2.5 billion of orders for a €500 million perpetual hybrid and launched a tender for its 6.00% 2022 hybrid.

The Swiss connectivity group has brought Ingun into its Industry segment, adding test probes and fixture systems to a business that posted strong first-half growth.

The agreements make tZERO a design partner for digital transfer-agent and broker-dealer infrastructure for ICE’s planned NYSE-affiliated tokenized securities platform.

SLB agreed to acquire Kelvion for about $4.1 billion, adding thermal-management and heat-exchange technologies as it expands deeper into AI data-center infrastructure.